Don't Miss

Versarien Plc Another year of great progress
Reabold Resources Plc Complete Parta Exploration Licence Farm-In
Surface Transforms plc Contract Award from German OEM 5
Versarien plc To showcase technology at Bristol event
Frenkel Topping Group Plc Comment re: Ogden rate
Versarien plc Receipt of Graphene REACH Registration
Elegant Hotels Group plc Non-Executive Chairman purchases more shares in company
Union Jack Oil plc Biscathorpe-2 Well Upgraded

DirectorsTalk Interviews LSE London Stock Exchange PLC Company Interviews

Home
News
Interviews
- Q & A’s
- Request an Interview
Reports / Research
Indices
News Alerts
- Share Price Alerts
About Us

Home » Reports » Hardman & Co (page 28)

Hardman & Co

Page 28 of 29« First...10 20 «25 26 272829 »

Free News Alerts

UK Broker Ratings

Polymetal International PLC 2.3% Potential Decrease Indicated by Berenberg
17th July 2019
Hochschild Mining Plc 17% Potential Decrease Indicated by Berenberg
17th July 2019
HSBC Holdings plc 10.5% Potential Decrease Indicated by Barclays Capital
17th July 2019
Jupiter Fund Management PLC 15.6% Potential Decrease Indicated by UBS
17th July 2019
Hays plc 24.2% Potential Upside Indicated by Liberum Capital
17th July 2019
Burberry Group plc 4.1% Potential Upside Indicated by Credit Suisse
17th July 2019
Royal Bank of Scotland Group plc 21.9% Potential Upside Indicated by Barclays Capital
17th July 2019
Pearson plc 28.2% Potential Upside Indicated by JP Morgan Cazenove
15th July 2019
Hiscox Ltd 1.5% Potential Decrease Indicated by JP Morgan Cazenove
15th July 2019
Access Intelligence plc 40% Potential Upside Indicated by finnCap
15th July 2019

Hardman & Co

Redx Pharma Phase I trial resumed
11th July 2019
Burford Capital Petersen appeals to investors
9th July 2019
Oxford BioMedica Eying up long-term value
8th July 2019
Arbuthnot Banking Group Plc Mortgage portfolio acquisitions
3rd July 2019
Volta Finance Manager’s Hardman & Co Forum presentation
2nd July 2019
The 600 Group Acquisition of CMS attractive and EPS-enhancing
2nd July 2019
Allergy Therapeutics plc Successful legal outcome removes uncertainty
1st July 2019
Oxford BioMedica De-leveraging the balance sheet
24th June 2019
Tissue Regenix Credit facilities expand cash runway to 2021
24th June 2019
Non-Standard Finance Back to basics
24th June 2019

Latest Interviews

INTERVIEW: Sativa Group ‘A Big Boost’ from Health Secretary’s Statement
16th July 2019
INTERVIEW: Union Jack Oil “In great shape” with latest Biscathorpe update
15th July 2019
INTERVIEW: Applied Graphene Materials excited about its new products – and with good reason
12th July 2019
INTERVIEW: Jubilee Metals Group Adding to earnings while aggressively pursuing further projects
12th July 2019

Currency Pairs

Share Price Alerts

Notify me when

GBP

Current value: loading...

Trending Articles

GVC Holdings PLC Post Close H1 Trading Update 17th July 2019
Premier Oil PLC Trading and Operations Update 17th July 2019
Tate & Lyle announces departure of President, Food & Beverage… 17th July 2019
Galliford Try plc Performed well, supported by good housing demand 17th July 2019

FTSE 100 News

Johnson Matthey PLC AGM trading update
17th July 2019
Micro Focus International plc New Share buy-back programme with initial tranche of up to $200m
17th July 2019
Severn Trent Plc Trading Update for the period 1st April to 17th July 2019
17th July 2019
Johnson Matthey PLC John Walker to retire; succeeded by Joan Braca
17th July 2019

FTSE 250 News

Euromoney Institutional Investor plc Reports record revenues for last quarter
17th July 2019
Acacia Mining PLC International arbitration and NEMC Prohibition Notice
17th July 2019
Galliford Try plc Performed well, supported by good housing demand
17th July 2019
CLS Holdings announces the sale of Quayside Lodge for £19m
17th July 2019

Request an Interview

MSN Money LSE LSE Wiki DirectorsTalk Financial Times Bing News FTSE 100 Market Cap Google Finance LSE News LSE Interviews

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2019 - DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.